DERMATA THERAPEUTICS, INC. Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
DERMATA THERAPEUTICS, INC. (DRMA) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-17.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2025-03-17
- DERMATA THERAPEUTICS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2024 was $0.00.
- DERMATA THERAPEUTICS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2023 was $0.00.
- DERMATA THERAPEUTICS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $0.00.
- DERMATA THERAPEUTICS, INC. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2021 was $0.00.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-17 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-17 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-21 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-21 |
| 2020-12-31 | $0.00 10-K · filed 2022-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |